knowledge -WSS

knowledge

author：fashion 2025-09-30 01:12:55 - browse：7

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Heart disease in astronauts blamed on cosmic radiation

WSS

CDC recommends RSV monoclonal antibody for infants

FDA scientists endorse Pfizer/BioNTech Covid

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

FDA approves Sage Therapeutics’ rapid

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Telehealth for opioid use disorder is lifesaving

focus

knowledge

knowledge

Alkermes shareholders re

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Medical leaders decry Supreme Court decision on affirmative action

Flint parents haunted by uncertainty, fears of lead poisoning

Heart attack and stroke risk calculators need revising

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

United colonoscopy coverage change 'may cost lives,' doctors say

Generate Biomedicines machine learning biotech raises $273M

Guidelines to prevent youth baseball injuries need more muscle

Food makers tried to stack nutrition panel with preferred experts

focus

Study links childhood stress with decline in older age

Pig kidney works a record two months in donated body

Regeneron agrees to White House price limits on anti

Acelyrin, a rare IPO success, stumbles in its first big test

Personalized medicine goes far beyond genetics

Group behind ProMed defends move to subscription

focus

focus

focus

focus